id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1981-N-0013-0020,FDA,FDA-1981-N-0013,HFD-560,Other,MT-Memorandum of Telephone Conversation,2004-11-30T05:00:00Z,2004,11,,,2008-05-30T22:52:48Z,,0,0,09000064805aec54
FDA-1981-N-0013-0019,FDA,FDA-1981-N-0013,"HFD-560 & Dyclo9, Inc.",Other,MT-Memorandum of Telephone Conversation,2004-11-08T05:00:00Z,2004,11,,,2008-05-30T22:53:02Z,,0,0,09000064805aec53
FDA-1981-N-0013-0016,FDA,FDA-1981-N-0013,HFD-560,Other,MM-Memorandum of Meeting,2004-09-15T04:00:00Z,2004,9,,,2008-05-30T22:52:55Z,,0,0,09000064805aec3b
FDA-1981-N-0013-0017,FDA,FDA-1981-N-0013,HFD-560,Other,MM-Memorandum of Meeting,2004-09-15T04:00:00Z,2004,9,,,2008-05-30T22:53:09Z,,0,0,09000064805aec3c
FDA-1981-N-0013-0014,FDA,FDA-1981-N-0013,"HFA-305 to Dyclo9, Inc.",Other,ACK-Acknowledgement Letter,2004-07-15T04:00:00Z,2004,7,,,2008-05-30T22:52:48Z,,0,0,09000064805aec39
FDA-1981-N-0013-0015,FDA,FDA-1981-N-0013,"HFA-305 to Dyclo9, Inc.",Other,ACK-Acknowledgement Letter,2004-07-15T04:00:00Z,2004,7,,,2008-05-30T22:52:26Z,,0,0,09000064805aec3a